Skip to main content
. 2018 Jun 26;62(7):e02584-17. doi: 10.1128/AAC.02584-17

FIG 1.

FIG 1

Activities of ceftazidime-avibactam (black bars) and ceftazidime (white bars) against 108 ceftazidime-nonsusceptible Enterobacteriaceae (determined for the microbiologically modified intent-to-treat [mMITT] patient analysis set). For Enterobacteriaceae, ceftazidime-nonsusceptible isolates were defined as those having a ceftazidime MIC of ≥8 mg/liter. mMITT includes 108 of the 109 ceftazidime-nonsusceptible Enterobacteriaceae isolates obtained from all randomized patients.